Consistent with this, we found that the long-term inhibition of SIK2 using MRIA9 significantly enhanced the chromosome number of SKOV-3 and OVCAR-3 cells, suggesting that SIK2 may play a critical role in maintaining genomic stability in ovarian cancers. This evidence concerns the gene SIK2 and ovarian carcinoma.